SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-24-011854 from FULLER H B CO (FUL) (CIK 0000039368) (FUL)

FULLER H B CO (FUL) (CIK 0000039368)
Date: April 12, 2024 · CIK: 0000039368 · Accession: 0001437749-24-011854

AI Filing Summary & Sentiment

File numbers found in text: 001-09225

Referenced dates: April 30, 2021, March 15, 2024

Date
April 12, 2024
Author
Branch Chief
Form
CORRESP
Company
FULLER H B CO (FUL) (CIK 0000039368)

Letter

VIA EDGAR Division of Corporation Finance Attention: Form 10-K For the fiscal year ended December 2, 2023 Filed January 24, 2024 Form 8-K dated January 17, 2024 File No. 001-09225

Dear Li Xiao:

This letter contains the responses of H.B. Fuller Company (the “Company,” “we,” or “our”) to the comments contained in the letter from the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”) dated March 15, 2024 regarding the reports referenced above. We have addressed your comment letter by reproducing each comment below and providing our response immediately thereafter.

Form 8-K dated January 17, 2024

Exhibit 99.1

Regulation G Reconciliation, page 8

1.

We note Project One was approved in 2012 and will continue beyond 2024. We note the execution of Project One is being supported by internal resources and consulting services. We note your organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies. We note you have approved restructuring “plans” in 2023, and previously complete plans include the 2020 Restructuring Plan, the 2017 Restructuring Plan, and the Royal Adhesives Restructuring Plan. We note acquisition project costs include costs related to integrating and accounting for acquisitions and there were approximately ten acquisitions over the past two fiscal years. We note you have previously provided information to the staff via your response letter dated April 30, 2021 and that certain of these expenses have become more significant since then and that currently certain of the descriptions related to the non-GAAP adjustments lack sufficient detail that would allow investors to fully assess your non-GAAP measure. As it relates to the acquisition project costs, organizational realignment costs and Project One costs included within your reconciliation to Adjusted net income attributable to H.B. Fuller, please more fully describe the nature of the specific costs that were incurred and any relevant details to understand the context of the costs being incurred. Please quantify any material categories within these non-GAAP adjustments. Please provide us any proposed changes. In addition, please reconcile for us the amount of acquisition project costs and organizational realignment costs presented here with the amount in Note 3: Restructuring Activities, of your financial statements.

U.S. Securities and Exchange Commission

April 12, 2024

Page 2

Acquisition project costs consist of transaction, purchase accounting and business integration costs. Transaction costs include consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses. Purchase accounting costs include professional fees for valuation services, inventory step-up cost and the impact of changes in contingent consideration liabilities after the completion of the purchase price allocation. Business integration costs include the cost of transitional services and retention plan costs for acquired employees.

Organization realignment costs consist of professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies.

Project ONE costs consist of non-capitalizable consulting fees and internal employee compensation and travel costs related to the design and implementation of our SAP ERP system.

In accordance with the Staff’s comment, in future earnings releases, we will more fully describe the above costs included in our reconciliation of Adjusted net income attributable to H.B. Fuller to Net income attributable to H.B. Fuller. Additionally, we will quantify material categories within those non-GAAP adjustments. An example of the disclosures to be included in our future earnings releases is presented below.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

Three Months Ended

Year Ended

December

2,

December

3,

December

2,

December

3,

Net income attributable to H.B. Fuller

$ 44,991

$ 48,305

$ 144,906

$ 180,313

Adjustments:

Acquisition project costs 1

4,765

1,822

16,874

10,830

Organizational realignment 2

10,549

1,471

29,900

6,386

Royal restructuring and integration 3

-

1,467

-

2,474

Project One 4

2,193

2,326

9,815

9,885

Other 5

(3,903 )

4,524

(611 )

12,791

Discrete tax items 6

16,955

1,610

26,085

9,308

Income tax effect on adjustments 7

(1,158 )

(3,911 )

(10,604 )

(10,699 )

Adjusted net income attributable to H.B. Fuller 8

74,392

57,614

216,365

221,288

Add:

Interest expense

33,297

30,046

131,913

91,547

Interest income

(1,217 )

(1,609 )

(3,943 )

(7,790 )

Income taxes

26,477

17,464

78,047

78,576

Depreciation and Amortization expense 9

39,653

37,469

158,456

146,394

Adjusted EBITDA 8

172,602

140,984

580,838

530,015

Diluted Shares

56,161

55,472

55,958

55,269

Adjusted diluted income per common share attributable to H.B. Fuller 8

$ 1.32

$ 1.04

$ 3.87

$ 4.00

Adjusted net revenue

$ 902,879

$ 958,213

$ 3,510,934

$ 3,749,183

Adjusted EBITDA margin 8

19.1

%

14.7 %

16.5 %

14.1 %

1 Acquisition project costs include costs related to evaluating, acquiring and integrating business acquisitions. Acquisition project costs include $1,421 and $1,090 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses), $1,489 and $732 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $1,855 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the three months ended December 2, 2023 and December 3, 2022, respectively. Acquisition project costs include $6,960 and $8,824 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition related travel expenses), $7,712 and $2,006 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $2,202 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the years ended December 2, 2023 and December 3, 2022, respectively.

U.S. Securities and Exchange Commission

April 12, 2024

Page 3

2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies. Organizational realignment includes $812 and $240 in professional fees related to legal entity and business structure changes, $8,110 and $1,105 in employee severance and other related costs, and $1,627 and $126 related to facility rationalization costs for the three months ended December 2, 2023 and December 3, 2022, respectively. Organizational realignment includes $1,525 and $2,484 in professional fees related to legal entity and business structure changes, $25,490 and $3,105 in employee severance and other related costs, and $2,885 and $797 related to facility rationalization costs for the year ended December 2, 2023 and December 3, 2022, respectively.

3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including professional fees related to the restructuring and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

4 Project One includes non-capitalizable project costs related implementing our global Enterprise Resource Planning system, including upgrading to SAP S/4HANA®, which will upgrade and standardize our information system.

As requested, a reconciliation of the adjustments contained in our Form 8-K compared to our disclosure in Note 3 to our Form 10-K related to the Organizational realignment and Royal restructuring and integration projects for fiscal year ended December 2, 2023 and December 3, 2022 is included below.

Fiscal year ended December 2, 2023

Form 10-K: Organizational realignment

$ 24,587

Internal personnel and other costs

(311 )

Professional fees and other external costs

3,431

Operating inefficiencies

2,193

Form 8-K: Organizational realignment

$ 29,900

Fiscal year ended December 3, 2022

Form 10-K: Organizational realignment

$ (352 )

Form 10-K: Royal restructuring and integration

$ (97 )

Internal personnel and other costs

4,173

Internal personnel and other costs

1,252

Professional fees and other external costs

2,509

Professional fees and other external costs

Operating inefficiencies

Operating inefficiencies

Form 8-K: Organizational realignment

$ 6,386

Form 8-K: Royal restructuring and integration

$ 2,474

2.

Please explain to us why you present discrete tax items as an adjustment to determine Adjusted net income attributable to H.B. Fuller, separate and apart from your income taxes adjustment to determine Adjusted EBITDA. In addition, please explain to us the circumstances related to earnings that are no longer invested.

The Company presents discrete tax items as an adjustment to determine adjusted net income attributable to H.B. Fuller separate from income tax adjustments to determine adjusted EBITDA because, in the Company’s view, those discrete tax items do not relate to current year adjusted pre-tax earnings. The discrete tax items, like the other adjustments used to determine adjusted net income attributable to H.B. Fuller, are generally non-recurring or otherwise not directly related to current year earnings. The income tax adjustments used to determine adjusted EBITDA, on the other hand, represent tax impacts related to current period earnings that are added back to adjusted net income attributable to H.B. Fuller to arrive at adjusted EBITDA.

U.S. Securities and Exchange Commission

April 12, 2024

Page 4

In calculating adjusted net income attributable to H.B. Fuller, the Company also adjusts for the income tax effects of the current year adjustments used to reconcile U.S. GAAP net income attributable to H.B. Fuller to adjusted net income attributable to H.B. Fuller. For fiscal year 2023, the discrete tax items of $26,085, income tax effect on adjustments of ($10,604) and income tax adjustments of $78,047, when taken together, equal the U.S. GAAP income tax expense of $93,529.

The circumstances related to earnings that are no longer invested involve the Company’s practice of not recording U.S. deferred income taxes for certain of its non-U.S. subsidiaries’ undistributed earnings because those amounts are intended to be indefinitely reinvested outside of the U.S. Company management continuously assesses the Company’s global and the individual non-U.S. subsidiary’s local cash needs in evaluating whether earnings are intended to be indefinitely reinvested. Potential cash needs include, without limitation, capital investment, working capital, repayment of debt and acquisitions. During the fourth quarter of fiscal year 2023, Company management concluded that it no longer intends to indefinitely reinvest a portion of the undistributed earnings held by certain of the Company’s non-U.S. subsidiaries. Based on that determination, the Company recorded withholding tax on those earnings.

3.

We note the headlines at the top of your news release refer to company achieves new record for Q4 and fiscal year adjusted EBITDA margin, and Q4 Adjusted EBITDA up 22% and Adjusted EBITDA margin up 440 basis points versus Q4 2022. Please tell us how you considered Non-GAAP Financial Measures C&DI 102.10(a) as it relates to the prominence of these non-GAAP measures in your news release.

The Company respectfully acknowledges the Staff’s comment and will revise its presentation of non-GAAP measures in future earnings releases, including in headlines, to include the comparable GAAP measure with equal or greater prominence as each non-GAAP measure in accordance with Non-GAAP Financial Measures C&DI 102.10(a).

Form 10-K For the fiscal year ended December 2, 2023

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations, page 24

4.

We note you attribute the 2023 300 basis points change in cost of sales and gross profit to lower raw material costs and higher product pricing partially offset by the impact of lower sales volume. Please provide us and in future filings more insight and specificity as it relates to each of these factors. For example, analyze and discuss the underlying raw materials and products at hand. In addition, please provide quantitative information as it relates to the contribution of each factor to the basis point change. Refer to Item 303(a), (b), and (b)(2) of Regulation S-K for the relevant MD&A requirements.

In accordance with the Staff’s comment, in future filings the Company will provide more specificity and quantitative information related to the impact of sales volumes, product pricing, raw material costs and other manufacturing costs on cost of sales and gross margin. The Company respectfully notes for the Staff that it uses thousands of raw materials to produce thousands of products across diverse global and regional markets. Therefore, in the Company’s opinion, a detailed disclosure regarding raw material costs and product pricing is not practical and would not provide meaningful information to the Company’s investors and other stakeholders as no individual raw material or product would have a significant effect on our financial results. An example of the more detailed disclosures to be included in our future filings is presented below.

Cost of sales

($ in millions)

2023 vs 2022

Cost of sales

$ 2,502.0

$ 2,785.5

(10.2 )%

Percent of net revenue

71.3 %

74.3 %

U

Show Raw Text
CORRESP
1
filename1.htm

	ful20240410_corresp.htm

			H.B. Fuller Company

			1200 Willow Lake Boulevard
			Correspondence to:

			St. Paul, Minnesota 55110-5101
			P.O. Box 64683

			St. Paul, Minnesota 55164-0683

April 12, 2024

VIA EDGAR

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549

			Attention:

			Li Xiao

			Branch Chief

			Re:

			H.B. Fuller Company

			Form 10-K For the fiscal year ended December 2, 2023

			Filed January 24, 2024

			Form 8-K dated January 17, 2024

			File No. 001-09225

Dear Li Xiao:

This letter contains the responses of H.B. Fuller Company (the “Company,” “we,” or “our”) to the comments contained in the letter from the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”) dated March 15, 2024 regarding the reports referenced above. We have addressed your comment letter by reproducing each comment below and providing our response immediately thereafter.

Form 8-K dated January 17, 2024

Exhibit 99.1

Regulation G Reconciliation, page 8

			1.

			We note Project One was approved in 2012 and will continue beyond 2024. We note the execution of Project One is being supported by internal resources and consulting services. We note your organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies. We note you have approved restructuring “plans” in 2023, and previously complete plans include the 2020 Restructuring Plan, the 2017 Restructuring Plan, and the Royal Adhesives Restructuring Plan. We note acquisition project costs include costs related to integrating and accounting for acquisitions and there were approximately ten acquisitions over the past two fiscal years. We note you have previously provided information to the staff via your response letter dated April 30, 2021 and that certain of these expenses have become more significant since then and that currently certain of the descriptions related to the non-GAAP adjustments lack sufficient detail that would allow investors to fully assess your non-GAAP measure. As it relates to the acquisition project costs, organizational realignment costs and Project One costs included within your reconciliation to Adjusted net income attributable to H.B. Fuller, please more fully describe the nature of the specific costs that were incurred and any relevant details to understand the context of the costs being incurred. Please quantify any material categories within these non-GAAP adjustments. Please provide us any proposed changes. In addition, please reconcile for us the amount of acquisition project costs and organizational realignment costs presented here with the amount in Note 3: Restructuring Activities, of your financial statements.

U.S. Securities and Exchange Commission

April 12, 2024

Page 2

Acquisition project costs consist of transaction, purchase accounting and business integration costs. Transaction costs include consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses. Purchase accounting costs include professional fees for valuation services, inventory step-up cost and the impact of changes in contingent consideration liabilities after the completion of the purchase price allocation. Business integration costs include the cost of transitional services and retention plan costs for acquired employees.

Organization realignment costs consist of professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies.

Project ONE costs consist of non-capitalizable consulting fees and internal employee compensation and travel costs related to the design and implementation of our SAP ERP system.

In accordance with the Staff’s comment, in future earnings releases, we will more fully describe the above costs included in our reconciliation of Adjusted net income attributable to H.B. Fuller to Net income attributable to H.B. Fuller. Additionally, we will quantify material categories within those non-GAAP adjustments. An example of the disclosures to be included in our future earnings releases is presented below.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

			Three Months Ended

			Year Ended

			December

			2,

			December

			3,

			December

			2,

			December

			3,

			2023

			2022

			2023

			2022

			Net income attributable to H.B. Fuller

			$
			44,991

			$
			48,305

			$
			144,906

			$
			180,313

			Adjustments:

			Acquisition project costs 1

			4,765

			1,822

			16,874

			10,830

			Organizational realignment 2

			10,549

			1,471

			29,900

			6,386

			Royal restructuring and integration 3

			-

			1,467

			-

			2,474

			Project One 4

			2,193

			2,326

			9,815

			9,885

			Other 5

			(3,903
			)

			4,524

			(611
			)

			12,791

			Discrete tax items 6

			16,955

			1,610

			26,085

			9,308

			Income tax effect on adjustments 7

			(1,158
			)

			(3,911
			)

			(10,604
			)

			(10,699
			)

			Adjusted net income attributable to H.B. Fuller 8

			74,392

			57,614

			216,365

			221,288

			Add:

			Interest expense

			33,297

			30,046

			131,913

			91,547

			Interest income

			(1,217
			)

			(1,609
			)

			(3,943
			)

			(7,790
			)

			Income taxes

			26,477

			17,464

			78,047

			78,576

			Depreciation and Amortization expense 9

			39,653

			37,469

			158,456

			146,394

			Adjusted EBITDA 8

			172,602

			140,984

			580,838

			530,015

			Diluted Shares

			56,161

			55,472

			55,958

			55,269

			Adjusted diluted income per common share attributable to H.B. Fuller 8

			$
			1.32

			$
			1.04

			$
			3.87

			$
			4.00

			Adjusted net revenue

			$
			902,879

			$
			958,213

			$
			3,510,934

			$
			3,749,183

			Adjusted EBITDA margin 8

			19.1

			%

			14.7
			%

			16.5
			%

			14.1
			%

1 Acquisition project costs include costs related to evaluating, acquiring and integrating business acquisitions. Acquisition project costs include $1,421 and $1,090 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition-related travel expenses), $1,489 and $732 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $1,855 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the three months ended December 2, 2023 and December 3, 2022, respectively. Acquisition project costs include $6,960 and $8,824 in transaction costs (primarily consulting and professional fees, representations and warranties insurance premiums and employee acquisition related travel expenses), $7,712 and $2,006 in purchasing accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $2,202 and $0 in business integration costs (primarily costs of transition services agreements and retention bonuses paid to employees of the acquired entities) for the years ended December 2, 2023 and December 3, 2022, respectively.

U.S. Securities and Exchange Commission

April 12, 2024

Page 3

2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and operational inefficiencies. Organizational realignment includes $812 and $240 in professional fees related to legal entity and business structure changes, $8,110 and $1,105 in employee severance and other related costs, and $1,627 and $126 related to facility rationalization costs for the three months ended December 2, 2023 and December 3, 2022, respectively. Organizational realignment includes $1,525 and $2,484 in professional fees related to legal entity and business structure changes, $25,490 and $3,105 in employee severance and other related costs, and $2,885 and $797 related to facility rationalization costs for the year ended December 2, 2023 and December 3, 2022, respectively.

3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including professional fees related to the restructuring and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

4 Project One includes non-capitalizable project costs related implementing our global Enterprise Resource Planning system, including upgrading to SAP S/4HANA®, which will upgrade and standardize our information system.

As requested, a reconciliation of the adjustments contained in our Form 8-K compared to our disclosure in Note 3 to our Form 10-K related to the Organizational realignment and Royal restructuring and integration projects for fiscal year ended December 2, 2023 and December 3, 2022 is included below.

			Fiscal year ended December 2, 2023

			Form 10-K: Organizational realignment

			$
			24,587

			Internal personnel and other costs

			(311
			)

			Professional fees and other external costs

			3,431

			Operating inefficiencies

			2,193

			Form 8-K: Organizational realignment

			$
			29,900

			Fiscal year ended December 3, 2022

			Form 10-K: Organizational realignment

			$
			(352
			)

			Form 10-K: Royal restructuring and integration

			$
			(97
			)

			Internal personnel and other costs

			4,173

			Internal personnel and other costs

			1,252

			Professional fees and other external costs

			2,509

			Professional fees and other external costs

			729

			Operating inefficiencies

			56

			Operating inefficiencies

			590

			Form 8-K: Organizational realignment

			$
			6,386

			Form 8-K: Royal restructuring and integration

			$
			2,474

			2.

			Please explain to us why you present discrete tax items as an adjustment to determine Adjusted net income attributable to H.B. Fuller, separate and apart from your income taxes adjustment to determine Adjusted EBITDA. In addition, please explain to us the circumstances related to earnings that are no longer invested.

The Company presents discrete tax items as an adjustment to determine adjusted net income attributable to H.B. Fuller separate from income tax adjustments to determine adjusted EBITDA because, in the Company’s view, those discrete tax items do not relate to current year adjusted pre-tax earnings. The discrete tax items, like the other adjustments used to determine adjusted net income attributable to H.B. Fuller, are generally non-recurring or otherwise not directly related to current year earnings. The income tax adjustments used to determine adjusted EBITDA, on the other hand, represent tax impacts related to current period earnings that are added back to adjusted net income attributable to H.B. Fuller to arrive at adjusted EBITDA.

U.S. Securities and Exchange Commission

April 12, 2024

Page 4

In calculating adjusted net income attributable to H.B. Fuller, the Company also adjusts for the income tax effects of the current year adjustments used to reconcile U.S. GAAP net income attributable to H.B. Fuller to adjusted net income attributable to H.B. Fuller.  For fiscal year 2023, the discrete tax items of $26,085, income tax effect on adjustments of ($10,604) and income tax adjustments of $78,047, when taken together, equal the U.S. GAAP income tax expense of $93,529.

The circumstances related to earnings that are no longer invested involve the Company’s practice of not recording U.S. deferred income taxes for certain of its non-U.S. subsidiaries’ undistributed earnings because those amounts are intended to be indefinitely reinvested outside of the U.S. Company management continuously assesses the Company’s global and the individual non-U.S. subsidiary’s local cash needs in evaluating whether earnings are intended to be indefinitely reinvested. Potential cash needs include, without limitation, capital investment, working capital, repayment of debt and acquisitions. During the fourth quarter of fiscal year 2023, Company management concluded that it no longer intends to indefinitely reinvest a portion of the undistributed earnings held by certain of the Company’s non-U.S. subsidiaries.  Based on that determination, the Company recorded withholding tax on those earnings.

			3.

			We note the headlines at the top of your news release refer to company achieves new record for Q4 and fiscal year adjusted EBITDA margin, and Q4 Adjusted EBITDA up 22% and Adjusted EBITDA margin up 440 basis points versus Q4 2022. Please tell us how you considered Non-GAAP Financial Measures C&DI 102.10(a) as it relates to the prominence of these non-GAAP measures in your news release.

The Company respectfully acknowledges the Staff’s comment and will revise its presentation of non-GAAP measures in future earnings releases, including in headlines, to include the comparable GAAP measure with equal or greater prominence as each non-GAAP measure in accordance with Non-GAAP Financial Measures C&DI 102.10(a).

Form 10-K For the fiscal year ended December 2, 2023

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations, page 24

			4.

			We note you attribute the 2023 300 basis points change in cost of sales and gross profit to lower raw material costs and higher product pricing partially offset by the impact of lower sales volume. Please provide us and in future filings more insight and specificity as it relates to each of these factors. For example, analyze and discuss the underlying raw materials and products at hand. In addition, please provide quantitative information as it relates to the contribution of each factor to the basis point change. Refer to Item 303(a), (b), and (b)(2) of Regulation S-K for the relevant MD&A requirements.

In accordance with the Staff’s comment, in future filings the Company will provide more specificity and quantitative information related to the impact of sales volumes, product pricing, raw material costs and other manufacturing costs on cost of sales and gross margin. The Company respectfully notes for the Staff that it uses thousands of raw materials to produce thousands of products across diverse global and regional markets. Therefore, in the Company’s opinion, a detailed disclosure regarding raw material costs and product pricing is not practical and would not provide meaningful information to the Company’s investors and other stakeholders as no individual raw material or product would have a significant effect on our financial results. An example of the more detailed disclosures to be included in our future filings is presented below.

Cost of sales

			($ in millions)

			2023

			2022

			2023 vs 2022

			Cost of sales

			$
			2,502.0

			$
			2,785.5

			(10.2
			)%

			Percent of net revenue

			71.3
			%

			74.3
			%

U